Is Promotion of Fecal Immunochemical Testing "FIT" to Address COVID-19 Disruptions to Colorectal Cancer Screening?
作者信息
Trivedi Mehul, Gupta Samir
机构信息
Department of Internal Medicine, University of California San Diego, La Jolla, California.
Veterans Affairs San Diego Healthcare System, San Diego, California; University of California San Diego, Division of Gastroenterology, Department of Internal Medicine, La Jolla, California.
出版信息
Gastroenterology. 2022 May;162(6):1761-1762. doi: 10.1053/j.gastro.2021.11.030. Epub 2021 Dec 1.
Abstract
摘要
相似文献
1
Is Promotion of Fecal Immunochemical Testing "FIT" to Address COVID-19 Disruptions to Colorectal Cancer Screening?推广粪便免疫化学检测（FIT）以应对新冠疫情对结直肠癌筛查的干扰？
Gastroenterology. 2022 May;162(6):1761-1762. doi: 10.1053/j.gastro.2021.11.030. Epub 2021 Dec 1.
2
The value of hypersensitivity quantitative fecal immunochemical test in early colorectal cancer detection.高敏定量粪便免疫化学检测在早期结直肠癌检测中的价值。
Postgrad Med J. 2024 Feb 15;100(1181):135-141. doi: 10.1093/postmj/qgad114.
3
FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.粪便潜血：化学检测与免疫化学检测的比较
Arq Gastroenterol. 2018 Apr-Jun;55(2):128-132. doi: 10.1590/S0004-2803.201800000-22.
4
Fecal Immunochemical Testing Compared With Colonoscopy.粪便免疫化学检测与结肠镜检查的比较
Am Fam Physician. 2023 Jun;107(6):642-644.
5
Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.新一代粪便免疫化学检测（FIT）与愈创木脂粪便潜血试验（gFOBT）在结肠镜转诊患者中检测结直肠肿瘤的比较。
Anticancer Res. 2019 Jan;39(1):261-269. doi: 10.21873/anticanres.13106.
6
Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.粪便免疫化学检测联合或不联合息肉切除术后监测结肠镜检查用于结直肠癌筛查的成本效果分析。
Ann Intern Med. 2017 Oct 17;167(8):544-554. doi: 10.7326/M16-2891. Epub 2017 Oct 3.
7
Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.基于人群的结直肠癌筛查中结肠镜检查和粪便免疫化学检测的优化使用：一项使用日本数据的成本效益分析
Jpn J Clin Oncol. 2016 Feb;46(2):116-25. doi: 10.1093/jjco/hyv186. Epub 2015 Dec 18.
8
Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal MicroRNA Signature With Fecal Immunochemical Test and Fecal Occult Blood Test.
Gastroenterology. 2024 Feb;166(2):358. doi: 10.1053/j.gastro.2023.06.012. Epub 2023 Jun 17.
9
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
10
Why do participants in the Flemish colorectal cancer screening program not undergo a diagnostic colonoscopy after a positive fecal immunochemical test?为什么参与弗拉芒结直肠癌筛查项目的人在粪便免疫化学检测呈阳性后不接受诊断性结肠镜检查？
Acta Clin Belg. 2022 Aug;77(4):760-766. doi: 10.1080/17843286.2021.1980675. Epub 2021 Sep 16.
Zotero 插件